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EVALUATING TECHNIQUES IN TISSUE CLARIFICATION USING CLARITY 
IMAGING AND INVESTIGATING WHERE SALT IS SENSED IN THE BODY 
CHRISTOPHER MATTHEW NEAL 
ABSTRACT 
Objective: 
 Previous studies have shown the significant contribution of sympathoinhibition in 
response to sodium loading to prevent increases in mean arterial blood pressure in salt 
resistant phenotypes. It has also been shown that brain Gαi2 protein gated signal 
transduction plays a major role in this pathway, however, the specific mechanisms through 
which this pathway is activated remain less well understood. The purpose of this study was 
to elucidate the relative contribution of increased sodium in either the plasma or the 
cerebrospinal fluid (CSF) to the regulation of mean arterial pressure and natriuresis. 
Additionally we explored the potential for using the novel CLARITY Imaging technique 
to identify the relative activity of neurons in areas of the brain thought to play a major role 
in body fluid homeostasis in response to salt. 
Methods: 
 Rats that were pre-treated with either scrambled or Gαi2 oligodeoxynucleotides 
(ODN), to selectively down regulate brain Gαi2 proteins, were challenged either 
peripherally or centrally with sodium. Upon sodium loading physiological parameters were 
measured for two hours after which the animal’s brains were recovered for 
immunohistochemical (IHC) analysis of the paraventricular nucleus, a known regulatory 
center for body fluid homeostasis and blood pressure regulation.  
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Additionally we adapted a version of the published CLARITY Imaging protocols 
for optically clearing tissue through application of electrophoretic tissue clearing (ETC) to 
a larger rat model.  
Results: 
 In scrambled ODN pre-treated rats we observed a temporary increase in MAP in 
response to both the peripheral and central sodium challenge. In the Gαi2 ODN pre-treated 
animals we saw some form of attenuation to this response in both studies, however, where 
in the peripheral challenge there was an increase in the amount of time that it took the rats 
to return to normotension with no alteration in natriuresis, in the central challenge there 
was a large attenuation in natriuresis with no differences in the time to return to baseline 
MAP. Our IHC analysis also showed a decrease in neuronal activation of paraventricular 
medial parvocellular neurons in Gαi2 pre-treated rats that were challenged peripherally vs 
their SCR pre-treated counterparts. No such difference was observed in either of the pre-
treatment groups from the central sodium challenge study.  
 In the CLARITY study we found that it is possible to adapt the method for optically 
clearing tissue to the larger model, however, we encountered several issues related to tissue 
swelling and peripheral tissue damage.  
Conclusion: 
 Based on our current results it seems evident that there are at least two different 
mechanisms that activate the cardiovascular regulatory control centers in the brain that 
prevent long term increases in mean arterial pressure in response to increased salt. It also 
appears that these two different mechanisms are triggered either by increases in plasma or 
  viii 
CSF salinity, though which of these two mechanisms may be directly responsible for the 
development of salt sensitive hypertension requires further investigation. 
 While we had some success at optically clearing larger tissue volumes through 
ETC, problems we encountered with maintaining tissue integrity for investigations of intact 
neural networks prevented us from applying this technique, in its current form, to our 
investigation of salt sensitive hypertension.  
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INTRODUCTION 
Hypertension 
Hypertension, a disease that currently afflicts more than 65 million adults in 
the United States (11) remains one of the most elusive problems in the realm of 
cardiovascular health. Despite an enormous research effort around the world for 
several decades, the underlying mechanisms through which the complex clinical 
phenotype of primary hypertension develops remain poorly understood. A large body 
of research in this field has been directed towards the influence of salt, with an 
emphasis on excess dietary salt, as a potentially significant factor in the pathogenesis 
of hypertension (33, 45, 46). It has been repeatedly shown that increased plasma 
sodium can have a profound effect on both the kidneys and the components of the 
central nervous system related to fluid and electrolyte balance, as well as control of 
cardiovascular output (7, 23, 45). It has also been shown that around half of all 
hypertensive patients show an increase in mean arterial pressure and sympathetic 
nerve activity in response to salt and that among those salt-sensitive individuals there 
is a significantly greater incidence of developing serious cardiovascular issues and 
mortality (57). What is not so well understood is the specific mechanism through 
which salt acts to alter normal physiological functioning. 
Salt sensitivity 
Primary to understanding the pathogenesis of salt-sensitive hypertension is 
the need to understand where specifically in the body sodium is sensed.  There is a 
substantial amount of research to support that there are several systems working 
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cooperatively to sense any changes in the sodium level in the plasma (7, 16, 28, 33). 
Systems of primary interest to the study of salt sensitive hypertension include the 
central nervous system (CNS), the kidneys and the sympathetic network through 
which they communicate. It has been shown that severing lines of communication 
between the CNS and the kidneys through renal denervation can attenuate the 
development of increased arterial blood pressure even in individuals who have been 
resistant to multiple different forms of therapies (50), although definitive results for 
the application of this method across the entire population remain elusive (5). 
Additional studies have shown in a rat model that ablation of the anteroventral third 
ventricle (AV3V) region have shown much the same attenuation in mean arterial 
pressure and natriuresis in response to salt as renal denervation (18, 42). 
Additionally lesions of the AV3V have been shown to abolish any influence of dietary 
salt to increasing blood pressure variability and normal cardiovascular reflexes in the 
salt resistant Sprague Dawley rat (42), although ablation of brain regions does not 
hold a great deal of promise for treatments in human beings. 
 It is worth noting that potential locations for the sensing of salt in addition to 
afferent arteriole baroreceptors of the kidneys have been found in some areas of the 
brain that have been associated with osmoregulation (17, 36). This complex system 
has created additional issues in understanding the pathogenesis of salt-sensitive 
hypertension given that abnormalities in the either the kidneys or the central nervous 
system can lead to the development of increased blood pressure (8, 26). For the 
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purposes of this study, the focus will be on those areas within the CNS that have been 
identified as likely areas for cardiovascular and osmotic regulation. 
Brain regions associated with maintaining body fluid homeostasis  
The areas that have been most closely linked to the development of salt 
sensitive hypertension can be primarily found in the forebrain lamina terminalis. 
These include the subfornical organ (SFO), and the organum vasculosum of the 
lamina terminalis (OVLT), collectively known as the sensory circumventricular 
organs (18). Also included are the median preoptic nucleus (MnPO) and the 
paraventricular nucleus (PVN). The SFO and OVLT have been shown to contain a 
number of sodium channels and osmo-receptors (35, 36), and their location adjoining 
the third ventricle and structure which allows access to both the blood as well as 
cerebrospinal fluid (CSF) make them likely possibilities for central sodium receptors. 
Additional studies have shown that projections from the CVOs are directed towards 
the MnPO as well as the PVN (20), sites that have been associated with summation of 
sensory inputs and relay stations for efferent signals to target organs and vasculature 
(7, 49). Several studies carried out to block sodium channels centrally or to ablate the 
entire region have shown a marked attenuation in the development of hypertension 
in the Dahl Salt Sensitive (DSS) rat when challenged with sodium (4, 22), although 
they do not totally stop the development of hypertension in spontaneously 
hypertensive rats (18). 
 One of the areas that has been a focus of these studies is the PVN, which is 
understood to be an area for the summation of sensory inputs from the sensory 
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organs and then a relay to those areas associated with sympathetic output such as the 
rostral ventrolateral medulla (RVLM) and intermediolateral cell column of the spinal 
cord (IML) (44). The PVN can be sub-divided into two separate groups of cells, the 
first group, the magnocellular neurons are thought to function primarily as endocrine 
cells that release , among other hormones, vasopressin (3, 49), a hormone 
traditionally associated with sodium and water balance. The second group of cells, 
the parvocellular neurons, work primarily as sympathetic-regulatory neurons 
projecting to endocrine control centers in the median eminence and limbic system as 
well as the RVLM and the IML (25). The parvocellular neurons can be further divided 
into the dorsal (dp), medial (mp), lateral (lp) and ventrolateral (vlp) parvocellular 
neurons based on their rostral-caudal position within the PVN (44) an illustration of 
these divisions can be found in appendix 1. It is thought that sympathetic output to 
the kidneys via the PVN may play a large role in the development of salt-sensitive 
hypertension. Studies have indicated that increased plasma sodium leads to 
increased activation in the CVOs (36) that then synapse with neurons within, among 
other regions, the PVN. PVN neurons will then go on to relay signals via the RVLM and 
IML to the kidneys via the renal efferent nerves. It has been shown that there is 
usually a sympathoinhibitory signal within the PVN which prevents too much renal 
sympathetic nerve activity in response to normal increases in plasma sodium 
associated with dietary intake. If not for this sympathoinhibition we would see a large 
increase in MAP after the consumption of any salt heavy meal (46, 54).  
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In recent years some interest has arisen as to what role G-protein coupled 
receptors might play in this sympathoinhibitory pathway. Early experiments from 
this laboratory have shown that activation of central α2-adrenoreceptors causes a 
marked diuretic and natriuretic response in concert with a decrease in both HR and 
MAP, however, this salt driven increase in MAP and natriuresis was blocked when 
animals were pre-treated with an oligodeoxynucleotide (ODN) targeted to central 
Gαi2 proteins (52). Further studies went on to show that in addition to α2-
adrenoreceptor activation central Gαi2 proteins also play an important role in renal 
sympathoinhibition associated with acute volume expansion, as well as global 
sympathoinhibition associated with acute iso-volumetric sodium loading and chronic 
stressful stimuli such as a high salt diet in rats (27, 54). Additionally it was found that 
renal denervation eliminated any differences in groups that were pre-treated with 
either Gαi2 or SCR ODN, from which we can infer that the Gαi2 protein gated signal 
transduction pathway is renal nerve dependent (26).  
Investigations of inter-connected neural networks through optically clearing 
biological tissues 
One of the challenges presented by neural research is the limited ability to 
study intact systems. Previous techniques such as electrophysiological, 
pharmacological and immunohistochemistry among others, while useful are 
constrained by the necessity to cut the brain into many slices, which inherently severs 
many connections which prevents imaging of total intact systems.  Systems level 
understanding has been the long sought golden standard through which we can hope 
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to fully understand not only the important components of a biological system but the 
manner in which they interact to allow the normal functioning of complex organisms. 
Whole brain imaging, with an emphasis on single cell resolution has become vital to 
our understanding of how certain neurological systems, such as those that regulate 
body fluid homeostasis, act to counter outside influences (31).  Clinical issues such as 
hypertension tend to affect several different neural systems spread throughout the 
brain and understanding the manner in which these systems communicate with one 
another is critical to understanding the pathology of the disease. Studies such as these 
meet with several practical barriers including the inability to image these connections 
in an intact subject. Recent technological advances have begun to make it possible to 
study fully intact neural networks via optically clearing tissue in order to better map 
the connections between different areas. 
 A method for preparing tissue such that neurological connections can be 
traced within an intact specimen have long been sought after. Early discoveries such 
as the Golgi stain have allowed for the investigation of single-cell connection within a 
complex organ, however the technology necessary to view such preparations has 
until recently been limited by the optical constraints of light microscopy. This has 
been especially true within the CNS due to the high optical scattering properties of 
lipid membranes (10) which are highly abundant in organisms that have mylenated 
axons. Several different techniques have emerged for optically clearing tissue in the 
past utilizing a variety of chemical reagents and processes. It was initially proposed 
that the incubation of organic samples in chemical compounds that matched the 
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refractory index of the proteins and lipids of primary interest would, theoretically, 
render the tissue transparent under light microscopy. Early techniques for the optical 
clearing have used immersion in alcohols (6), urea (19), and fructose in conjunction 
with thiols (29) to attempt to match the refractory index of the target organs. While 
some measure of success was attained with these techniques several unresolved 
issue including tissue shrinking/swelling and florescent marker washout have led 
researchers to continue to pursue alternative methods for optically clearing tissue.  
CLARITY 
Clear Lipid-exchanged Acrylamide-hybridized Rigid Imaging-compatible 
Tissue-hYdrogel (CLARITY) is a novel technique that couples the use of a rigid 
hydrogel perfusion in conjunction with an electrophoretic lipid clearing process to 
produce an optically clear tissue-hydrogel hybrid sample in which most proteins and 
nucleic acids remain intact and neural projections can still be identified (12, 13). This 
technique stands out from those previously utilized in that instead of trying to 
submerge tissue in a medium with a refractory index close to that of lipids, CLARITY 
actually removes lipid membranes leaving a much more optically clear sample. The 
use of acrylamide monomers and a heat activated initiator to polymerization meant 
that a semi-rigid lattice could be formed within cell membranes that would hold any 
hydrophilic molecules in place without binding any of the membrane lipids. Once this 
hydrogel structure is in place it then becomes possible to clear away the membrane 
lipids using a detergent such as SDS, leaving intact tissue that is optically clear.  Using 
electrophoresis to push SDS micelles deep into tissue has meant that much thicker 
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tissue samples could be cleared than previously, allowing for the examination of 
many more geographically distant intact structures. Also because the majority of 
proteins an nucleic acids are preserved in such a sample it becomes possible to apply 
stains after tissue clearing meaning that any signal loss is minimized and repeated 
rounds of staining on any sample becomes possible.  
The application of this technique to understanding the integrative role of 
central osmo/sodium receptors, renal afferent input as well as input from other baro-
receptors that leads to the normal sympathoinhibition holds much promise in further 
identifying and understanding pathologies in salt sensitive populations.  
Specific Aims 
The specific aims of this study are three-fold. 
1. The first was to examine neural activation in the hypothalamic paraventricular 
nucleus, as well as monitoring the diuretic, natriuretic and cardiovascular 
response to a central sodium load and to elucidate the significance of central Gαi2 
proteins in this response. 
2. Secondly to examine neural activation in those same areas as well as any 
physiological response to acute peripheral sodium loading in animals from both 
SCR and Gαi2 pre-treatment groups. 
3. Finally to test the potential efficacy of the CLARITY imaging technique on a 
larger rat model, with the intention of carrying out studies on the communications 
between brain areas that have been associated with the maintenance of body fluid 
homeostasis in response to salt. 
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METHODS 
 
Animals 
  Male Sprague-Dawley (SD) rats (Harlan Laboratories Inc., IN) weighing 275-
300g were individually housed in a temperature- (range: 68-79°F) and humidity-
controlled (range: 30-70%) environment under a 12-h light/dark cycle and were 
randomly assigned to experimental treatment groups. Rats were allowed tap water 
and standard rodent diet (Test Diet, St. Louis, MO, USA) ad libitum. All experimental 
protocols were approved by the Institutional Animal Care and Use Committee in 
accordance with the guidelines of Boston University School of Medicine and the 
National Institutes of Health Guide for the Care and Use of Laboratory Animals. 
 
Surgical Procedures 
 Intracerebroventricular (ICV) cannulae implantation 
 Animals were anesthetized (ketamine, 30 mg/kg intraperitoneally [IP] in 
combination with xylazine, 3 mg/kg IP) and stereotaxically implanted with a stainless 
steel cannula into the right lateral cerebral ventricle 5-7 days prior to 
experimentation, as previously described (26, 51-54). 
 
 Acute femoral vein, artery, and bladder cannulation 
  On the day of the study, intracerebroventricular (ICV) scrambled (SCR) or Gαi2 
oligodeoxynucleotide (ODN) pretreated (PT) rats were anesthetized with sodium 
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methohexital (20 mg/kg IP, supplemented with 10 mg/kg intravenously [IV] as 
required) and instrumented with catheters in the left femoral vein, left femoral artery, 
and bladder for administration of an isotonic saline infusion, measurement of heart 
rate (HR) and arterial blood pressure (MAP), and renal function, respectively (27, 52, 
54). 
 
Experimental Protocols 
 Acute ICV ODN administration 
 Twenty-four hours prior to the day of the study, down regulation of brain Gαi2 
protein expression levels in rats was achieved by ICV injection (25 μg/5μl delivered 
over 60- sec) of a phosphodiesterase ODN probe dissolved in isotonic saline that 
selectively targets Gαi2 proteins (5’-CTT GTC GAT CAT CTT AGA-3’) (27, 51, 54). 
Control studies involved ICV injection of a SCR ODN (5’-GGG CGA AGT AGG TCT TGG-
3’) (The Midland Certified Reagent Company Inc., Midland, TX, USA). An NCBI Basic 
LocalAlignment Search Tool search of the Rattus norvegicus RefSeq protein database 
was conducted to confirm the specificity of the Gαi2 ODN for the rat Gαi2 protein 
sequence and that the SCR ODN does not match any known rat protein sequence. 
Multiple publications from our laboratory have confirmed effective (~85%) ODN-
mediated down regulation of Gαi2 protein expression in the acute setting as assessed 
by Western blotting (26, 51-54). This was not carried out in the current study since 
the tissue processing required for immunohistochemical analysis rendered the tissue 
unusable for western blotting. 
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Acute central sodium challenge 
 Following femoral vein, artery, and bladder cannulation (as outlined above), 
rats were placed in a Plexiglas holder and an IV infusion of isotonic saline (20 μl/min) 
was maintained for a 2-h surgical recovery period prior to experimentation to enable 
the animal to regain full consciousness and for cardiovascular and renal excretory 
functions to stabilize. HR and MAP were continuously recorded via the surgically 
implanted femoral artery cannula using computer-driven BIOPAC data acquisition 
software (MP150 and AcqKnowledge 3.8.2, Goleta, CA, USA) connected to an external 
pressure transducer (P23XL; Viggo Spectramed Inc., San Francisco, CA, USA) (27, 52, 
54). Following the 2-h recovery period, baseline HR and MAP were recorded 
continuously over a 20-min control period in conscious rats. After measurement of 
baseline parameters, animals received a central sodium challenge: ICV injection of 
5µL of 1M NaCl over 30 seconds (42) and changes in HR and MAP were continuously 
recorded for 120-min and urine was collected in 10-min increments for the duration 
of the experiment (N=4/treatment group/time point). 
 
Acute peripheral sodium challenge 
Following femoral vein, artery, and bladder cannulation and recovery (as 
outlined above), baseline HR and MAP were recorded continuously over a 20-min 
control period in conscious rats. After measurement of baseline parameters, animals 
received a peripheral sodium challenge: IV bolus dose of 3M NaCl (0.14 ml/100g 
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delivered over 30-sec) (4) and changes in HR and MAP were continuously recorded 
for 120-min and urine was collected in 10-min increments for the duration of the 
experiment (N=6/treatment group/time point)  
 
Central Nervous System Tissue Collection 
Following completion of the acute sodium challenge protocol, rats were deeply 
anesthetized with sodium methohexital (10 mg/kg IV) and immediately perfused 
transcardially with 0.2-0.3 L of 0.1M phosphate-buffered saline (PBS) followed by 4% 
paraformaldehyde (PFA) in 0.1M PBS (4°C, 0.3-0.5 L). The brains were removed and 
placed in a vial containing 4% PFA in PBS overnight and then switched to a 30% w/v 
sucrose solution for two days (41). The PVN was sectioned into three separate sets of 
serial 40-μm coronal sections that were collected into a cryoprotectant [30% sucrose 
+30% ethylene glycol + 1% polyvinyl-pyrrolidone in 0.1M PBS] and stored at -20°C 
until they were processed for immunohistochemistry. 
 
Fos Immunoreactivity and Histological Analysis 
Free-floating sections from each brain were processed for rabbit polyclonal 
anti-Fos antibody (Calbiochem, San Diego, CA, USA) as previously described (41). 
Briefly, sections were brought to room temperature and rinsed twice for 30-min in 
0.1M PBS to remove cryoprotectant. Sections were incubated in 0.3% hydrogen 
peroxide in distilled water for 30-min at room temperature then rinsed for 30-min in 
0.1M PBS. Sections were then incubated for 2-h at room temperature in PBS diluent 
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[3% normal horse serum in 0.1M PBS containing 0.25% Triton-100 (Sigma- Aldrich, 
St. Louis, MO, USA)]. The rabbit polyclonal anti-Fos antibody was diluted to 1:30,000 
in PBS diluent and the sections were incubated in the primary antibody for 48- h at 
4°C. After two 30-min rinses in 0.1M PBS, sections were incubated in a biotinylated 
horse anti-rabbit IgG (Vector Laboratories, Burlingame, CA, USA) diluted to 1:200 in 
PBS diluent for 2-h at room temperature. The tissue was reacted with an avidin 
peroxidase conjugate (ABC-Vectastain kit; Vector Laboratories, Burlingame, CA, USA) 
and PBS containing 0.04% 3,3’-diaminobenzidene hydrochloride and 0.04% nickel 
ammonium sulfate (Sigma-Aldrich, St. Louis, MO, USA). Sections were mounted on gel 
coated slides, processed through a series of dehydrating alcohols followed by xylenes, 
and placed under a coverslip with Permount mounting medium. Tissue sections were 
analyzed using an Olympus microscope (BX41) equipped for epifluorescence and an 
Olympus DP70 digital camera with DP manager software (v2.2.1). The PVN was 
identified using the stereotaxic atlas of Paxinos and Watson (40) and sampled at three 
rostral-caudal levels, as previously described (44) see illustration in appendix. Care 
was taken to ensure that the sections used were from the same rostral-caudal plane 
in each brain. Analysis was performed on two sets of tissue for each animal. The 
number of Fos-positive cells were visually quantified by participants blind to the 
experimental conditions using National Institutes of Health ImageJ software and the 
counts for the total PVN and each subnucleus were averaged for each animal.  
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Analytical Techniques 
Analysis of Urine 
Urine volume was determined gravimetrically assuming 1g = 1ml. Urinary 
Sodium was measured using a flame photometer (model: 943, Instrumentation 
Laboratory, Bedford, MA, USA) (26, 27, 51, 52, 54). 
 
Statistical Analysis 
Results are expressed as mean ± SEM. The magnitude of changes in 
cardiovascular and renal excretory parameters at different time points after ICV 
sodium challenge were compared with respective group control values by a one-way 
repeated-measures (RM) ANOVA with a subsequent Dunnett’s multiple comparison 
test (GraphPad Prism v. 6.00 for PC OS; GraphPad Software, San Diego, CA, USA). For 
consistency the same controls were used for all parts of the experiment. Differences 
occurring between treatment groups were assessed by a two-way RM (mixed model) 
ANOVA (treatment x time). The time (minutes) was the repeated factor and post hoc 
analysis was performed using the Bonferroni’s post-test. The number of Fos positive 
cells in each subregion of interest was compared with respective group control values 
by a one-way RM ANOVA and between groups by a two-way RM ANOVA with a 
subsequent Dunnett’s multiple comparison test and Bonferroni’s post-test, 
respectively. 
In each case, statistical significance was defined as P<0.05.  
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Clarity  
Hydrogel 
Animals were deeply anesthetized with sodium methohexital (20 mg/kg IP) 
and immediately perfused transcardially with 75-80mL of 4°C hydrogel solution (4% 
paraformaldehyde, 4% Acrylamide in a 0.1M PBS solution with an additional 0.05% 
Bismuth buffer and 0.25% VA-044 heat activated Initiator). After perfusion the brains 
were recovered and placed into cold hydrogel solution where they were stored at 4°C 
for seven days (12). 
 
De-gassing 
After seven days the samples were degassed in a desiccation chamber where 
oxygen was removed and nitrogen gas was introduced. After degassing the samples 
were placed in a 37°C water-bath for four hours during which time the acrylamide 
monomers polymerized into a gelatinous matrix.  
 
Clearing  
After polymerization occurs the additional hydrogel was gently pulled away 
from the tissue using gloved hands, and then the brain was placed into a clearing 
solution (dH20, 4% Sodium Dodecyl Sulfate, and NaOH pellets to pH 8.5). After three 
days during which time additional hydrogel is dialyzed from the tissue, the brains 
were placed into a specially constructed electrophoresis chamber connected to a 
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water circulator circulating clearing solution heated to 37°C, electrophoresis was run 
at 30V over five days. After five days the tissue was removed from the electrophoresis 
chamber and rinsed in 0.1M PBS with 0.1% Triton after which it was placed into a 
solution of focus clear (CelExplorer labs Co., Hsinchu, Taiwan) (12). 
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RESULTS 
 
Effects of central sodium challenge on cardiovascular and renal excretory 
function 
Following 5µL 1M NaCl ICV injection no difference in peak bradycardia (ICV 
1M NaCl ΔHR [bpm]; SCR: -24±16 vs. Gαi2: -37±15, P>0.05) (Fig 1A) or peak change 
in mean arterial pressure (MAP) was observed between the two groups (ICV 1M NaCl 
ΔMAP [mmHg] SCR: +6±3 mmHg vs. Gαi2: +10±2, P>0.05). In both treatment groups 
MAP returned to baseline values within 120 min of treatment (MAP 120-min post 
NaCl [mmHg] SCR: 126±2 vs. Gαi2: 129±2, P >0.05) (Fig 1B). 
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Fig. 1 A Heart rate (BPM) response to 1M NaCl ICV injection (5µL) in conscious male SD rats 
pretreated ICV with a SCR or Gαi2 ODN (25µg/5µL) (N=4/group). Data are mean ± SEM 
(N=4/group). B. Mean arterial pressure (mmHg) in response to 1M NaCl ICV injection 
(5µL) in conscious male SD rats pretreated ICV with a SCR or Gαi2 ODN (25µg/5µL). 
Data are mean ± SEM (N=4/group).  
 
 
A B 
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Cumulative sodium excretion was significantly greater in the SCR PT group compared 
to the Gαi2 PT group over the course of the 120 minutes (Fig 2). 
 
Fig. 2. Cumulative sodium excretion in response to 1M NaCl ICV injection (5µL) in conscious 
male SD rats pretreated ICV with a SCR or Gαi2 ODN (25µg/5µL) (N=4/group). Data are 
mean ± SEM (N=4/group). *P <0.05, sig. diff vs. respective control value, τP<0.05, sig. 
diff. vs. respective SCR ODN value. 
 
 
Effect of peripheral sodium challenge on cardiovascular and renal excretory 
parameters  
Following IV bolus sodium challenge in male SD rats PT with a Gαi2- or SCR 
ODN, peak bradycardia was significantly greater in SCR animals as compared to Gαi2 
animals (IV 3M NaCl ΔHR [bpm]; SCR: -79±15 vs. Gαi2: -59±12, P<0.05). No difference 
was observed in peak changes in MAP (IV 3M NaCl ΔMAP [mmHg] SCR: +17±4 mmHg 
vs. Gαi2: +13±3, P>0.05). In SCR PT rats, MAP returned to baseline by 100-min whereas 
in Gαi2 PT rats MAP remained significantly elevated (MAP 100-min post NaCl [mmHg] 
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SCR: 134±2 vs. Gαi2: 146±3, P<0.05) (Fig. 3). There was no observable difference in any 
renal excretory parameters between the two groups (data not shown). 
 
Fig. 3. A Heart rate (BPM) and B. MAP (mmHg) responses produced by 3M NaCl IV bolus (0.14 
mL/100g) in conscious male SD rats pretreated ICV with a SCR or Gαi2 ODN (25 μg/5 
μL) (N=8/group). Data are mean  SEM (N=8/group). *P<0.05, sig. diff. vs. respective 
control value, τP<0.05, sig. diff. vs. respective SCR ODN value. 
 
Effects of central sodium challenge on Fos production within the PVN 
The total number of Fos-positive (Fos+) cells was not significantly different at 
control between treatment groups ([PVN Fos+ cells] SCR: 17±1 vs. Gαi2 control: 14±2, 
P>0.05). By 120-min, the level of Fos+ cells in both groups were significantly greater 
than their respective control levels, with no significant difference in activation 
between the two groups ([PVN Fos+ cells] SCR: 97±10 vs. Gαi2 120 min: 99±10, 
P>0.05) Fig 4. Due to the absence of a difference between the two groups we chose to 
observe only one time point at 120 min, at which point the animals had returned to 
baseline MAP and HR. 
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Fig. 4. Mean number (per section) ± SEM of total PVN Fos+ nuclei in ICV SCR ODN- or Gαi2 
ODN- pre-treated male SD rats at control, and 120 min post ICV NaCl administration 
(N=3/group/time point). *P<0.05, sig. diff. vs. respective control value.  
  
Effects of central sodium challenge on Fos production in PVN magnocellular 
neurons 
PVN Fos immunoreactivity was further analyzed by subnuclei whose 
cytoarchitechtonic boundaries were determined based on the rostral-caudal level of 
each section (44). The total number of Fos+ magnocellular neurons (i.e., posterior 
magnocellular [PM]) was significantly greater at 120-min post-NaCl administration 
as compared to control in both SCR and Gαi2 PT groups ([PM Fos+ cells] SCR control: 
3±1 vs. 120-min post-NaCl: 13±2; Gαi2 control: 2±0 vs. 120-min post-NaCl: 15±3, 
P<0.05). There were no significant differences between SCR and Gαi2 PT groups at 
any time point (Fig. 5). 
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Fig 5. Mean number (per section) ± SEM of total PVN Magnocellular Fos+ nuclei in ICV SCR 
ODN- or Gαi2 ODN- pre-treated male SD rats at control, and 120 min post ICV NaCl 
administration (N=3/group/time point). *P<0.05, sig. diff. vs. respective control value.  
 
 
Effect of central sodium challenge on Fos immunoreactivity in PVN 
parvocellular neurons  
PVN parvocellular neurons were further analyzed as dorsal (DP), medial (MP), 
and ventrolateral (VLP) subregions based on the respective rostral-caudal level of the 
PVN. No differences between the PT groups in the number of Fos+ nuclei were 
observed in any parvocellular subregions prior to sodium challenge ([DP Fos+ cells] 
SCR control: 4±0 vs. Gαi2 control: 4±0, P>0.05, [MP Fos+ cells] SCR control: 8±1 vs. 
Gαi2 control: 6±1, P>0.05, [VLP Fos+ cells] SCR control: 5±1 vs. Gαi2 control: 4±1, 
P>0.05). At 120-min, both SCR and Gαi2 PT rats exhibited significant increases in DP, 
MP, and VLP regions as compared to control but no significant differences between 
treatment groups ([DP Fos+ cells] SCR 120 min: 15±3 vs. Gαi2 120 min: 13±2, P<0.05, 
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[MP Fos+ cells] SCR 120 min: 60±3 vs. Gαi2 120 min: 54±6, P<0.05, [VLP Fos+ cells] 
SCR 120 min: 16±3 vs. Gαi2120 min: 23±3, P<0.05) Fig 6.   
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Fig 6. Mean number (per section) ± SEM of total PVN Parvocellular Fos+ nuclei in ICV SCR 
ODN- or Gαi2 ODN- pre-treated male SD rats at control, and 120 min post ICV NaCl 
administration (N=3/group/time point). *P<0.05, sig. diff. vs. respective control value 
 
Effect of peripheral sodium challenge on total PVN Fos immunoreactivity 
The total number of Fos+ cells was not significantly different at control between 
treatment groups, for the purpose of continuity the same controls were used for both the 
central as well as peripheral sodium challenges ([PVN Fos+ cells] SCR: 17±1 vs. Gαi2 
control: 14±2, P>0.05). At 40-min post-NaCl administration, a significant increase in Fos 
immunoreactivity was observed in SCR, but not Gαi2 PT rats ([PVN Fos+ cells] SCR 
control: 17±1 vs. 40-min post-NaCl: 52±5, P<0.05; Gαi2 control: 14±2 vs. 40-min post- 
NaCl: 30±6). Gαi2 PT rats also displayed significantly less Fos+ nuclei compared to the 
respective SCR PT rats ([PVN Fos+ cells] SCR 40-min post-NaCl: 52±5 vs. Gαi2 40-min 
post-NaCl: 30±6, P<0.05). By 100-min, the level of Fos positive cells in both groups were 
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significantly greater than their respective control levels, yet Gαi2 PT rats continued to 
display significantly less Fos+ nuclei compared to their respective SCR PT group value 
([PVN Fos+ cells] SCR 100-min post- NaCl: 107±14 vs. Gαi2 100-min post-NaCl: 65±10, 
P<0.05) Fig 7. 
 
Fig 7. Mean number (per section) ± SEM of total PVN Fos+ nuclei in IV SCR ODN- or Gαi2 ODN- 
pre-treated male SD rats at control, 40 min and 100 min post IV NaCl administration 
(N=8/group/time point). *P<0.05, sig. diff. vs. respective control value. τP<0.05, sig. diff. 
vs respective SCR ODN 
 
 
Effect of peripheral sodium challenge on Fos immunoreactivity in PVN 
magnocellular neurons 
The total number of Fos+ magnocellular neurons (i.e., posterior magnocellular 
[PM]) was significantly greater at 100-min post-NaCl administration as compared to 
control in both SCR and Gαi2 PT groups ([PM Fos+ cells] SCR control: 3±1 vs. 100-min 
post-NaCl: 31±5; Gαi2 control: 2±0 vs. 100-min post-NaCl: 26±4, P<0.05). There were no 
significant differences between SCR and Gαi2 PT groups at any time point. Fig 8.  
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Fig 8. Mean number (per section) ± SEM of total PVN Magnocellular Fos+ nuclei in IV SCR ODN- 
or Gαi2 ODN- pre-treated male SD rats at control, 40 min and 100 min post ICV NaCl 
administration. *p<0.05 sig. diff. vs respective control value. 
 
Effect of peripheral sodium challenge on Fos immunoreactivity in PVN 
parvocellular neurons  
No differences between the PT groups in the number of Fos+ nuclei were observed 
in any parvocellular sub regions prior to sodium challenge. At 40 min, acute sodium 
challenge significantly increased Fos immunoreactivity in the MP region in the SCR PT 
group ([MP Fos+ cells] SCR control: 8±1 vs. 40-min post-NaCl: 29±4, P<0.05), while no 
differences in any region were observed in the Gαi2 PT group as compared to respective 
control levels. At 100-min, SCR PT rats exhibited significant increases in DP, MP, VLP, 
and LP regions as compared to control. As compared to Gαi2 PT rats, SCR PT rats exhibited 
significantly more Fos+ cells in MP, VLP, and LP regions (Fig 9).  
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Fig 9. Mean number (per section) ± SEM of total PVN Parvocellular Fos+ nuclei in ICV SCR 
ODN- or Gαi2 ODN- pre-treated male SD rats at control, 40 min and 100 min post IV 3M 
NaCl administration (N=8/group/time point). *P<0.05, sig. diff. vs. respective control value. 
τP<0.05, sig. diff. vs respective SCR ODN 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Y
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Fig 10. 
 
 
 
 
 
 
 
 
Fig 10. Representative images of total PVN Fos-positive nuclei at level 2 in ICV SCR ODN- (A-
C) or Gαi2 ODN- (D-F) pretreated male SD rats at control, 40-min, and 100-min post- peripheral 
sodium challenge. PVN Fos-positive nuclei at level 2 in ICV SCR ODN (G), or Gαi2 ODN (H) at 
120-min post central sodium challenge. 
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Clarity 
Trial 1 
In order to accommodate for the larger size of the animals used (i.e., Rats vs. 
Mice) some minor changes were made to the initial experimental protocol (12). The 
initial perfusions were carried out according to the initial protocol, though a greater 
amount of Hydrogel was used; 75mL at a perfusion rate of 100 RPMs. The samples 
were stored in 35mL of hydrogel at 4°C for 8 days prior to degassing. After degassing 
and nitrogen addition all samples were placed in a water bath at 37°C for 4 hours to 
allow polymerization to occur. Post polymerization the samples were removed from 
the hydrogel matrix and placed into clearing solution for a total of 7 days, additional 
time of 4 days was included prior to electrophoretic tissue clearing (ETC)  in order to 
account for increased size of specimens [Original protocol specifies at least 3 days 
(12, 13)]. ETC was begun for samples N1 and N2 7 days post degassing at an original 
temp of 40°C and voltage of 15V. After 3 days of ETC samples were removed from 
chambers and examined, clearing was seen in much of the outer cortex however some 
physical trauma was observed in the already cleared tissue. In order to minimize 
damage to cleared tissue the samples were removed from the IHC chambers that had 
been holding them in place within the ETC chamber. At this time due to equipment 
constraints, voltage of electrophoresis was turned down to 10V for the remainder of 
run, all additional samples were run using a power source that allowed for 
significantly higher current. Samples were run for an additional 3 days at 10V and 
40°C. Upon removal from ETC it was discovered that specimen N2 had been mostly 
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dissolved, this is thought to be from constant abrasive action of moving fluid and 
limited protection from movement within the chamber. Sample N1 had a strong 
degree of clearing with only some parts of the mid brain remaining opaque, physical 
trauma to the outer cortex were noted although the general structure was preserved 
well. In both samples a large amount of swelling was observed. Fig 11. 
 
 
Fig 11. Rat brain prior to ETC treatment. Right hemisphere rat brain treated with Clarity Imaging 
Technique 
 
 
Samples N3 and N4 were begun on ETC 14 days post degassing at 37° and 30V. 
In order to prevent continuing external trauma samples were sealed into small mesh 
bags, N3 was clipped in using a staple, N4 was sewn in with silk sutures. ETC for this 
stage was inconsistent due to failure in one of the chambers, so sample N4 was placed 
back into clearing solution at 20°C for holding. Sample N3 was placed into functioning 
chamber and begun at highest recommended electrophoresis setting of 50°C at 60V. 
After 3 days sample was removed from ETC chamber and was found to be burnt 
beyond recognition leaving only some black remnants, burning thought to be due to 
Control N1 
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contact of the staple with either of the chamber electrodes when the specimen shifted 
within the chamber. Due to result destruction of sample N3 all potentially conductive 
equipment was removed from ETC setup and sample N4 was begun at 50°C and 60V. 
After 3 days specimen showed initial signs of clearing in the outer cortex however 
burning was also occurring along one side so additional ETC was discontinued Fig 12.  
  
 
Fig 12. N3 and N4 rat brains treated with electrophoretic tissue clearing, for CLARITY Imaging  
 
 
 
Trial 2 
Animals N5 and N6 were perfused with 75mL of Hydrogel (4°C) for 10 min at 
85rpm. After perfusion samples were left in additional 35mL hydrogel and stored for 
7 days (4°C). After 45 min under a vacuum (-.01 atm) and addition of nitrogen gas 
samples were placed into a 37°C water bath for 4 hours and then placed into clearing 
solution at 20°C for 7 days. Samples were placed into IHC cell strainers that were 
sewn together to minimize tissue movement and to prevent contact with electrodes. 
ETC was run at 37°C and 30V for 7 days, with clearing solution changed after 3 days, 
N3 N4 Control 
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after which samples were removed and rinsed in 0.1M PBST 3x before finally being 
placed in Focus clear solution Fig 13. The best result was seen in sample N6 which 
was almost entirely transparent, sample N5 was almost as clear though some opaque 
tissue remained in the mid brain. While clearing was remarkably increased in these 
samples there was still a large degree of swelling. 
 
 
Fig 13. N5 and N6 rat brains treated with electrophoretic tissue clearing, for CLARITY 
 
 
Trial 3 
Samples N9 and N10 were perfused and degassed following the protocol 
established in trial 2. After polymerization specimens were placed into clearing 
solution at 20°C for 7 days. Both samples were placed into IHC cell strainers and sewn 
in as in trial 2 and ETC was begun at 50°C and 60V. After 3 days samples were 
removed from ETC and examined Fig 14. A large degree of clearing was observed, 
however a much greater degree of damage to the outer cortical layers was also seen, 
this effect was contributed to the combined stresses of heat and current.  
N5 N6 Control 
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Fig 14. N9 and N10 rat brains treated with electrophoretic tissue clearing, for CLARITY 
 
 
Trial 4 
Samples N11 and N12 were perfused, degassed and held in clearing following 
protocol established in trial 2. After 7 days in clearing solution samples were placed 
in ETC chambers and run at 20°C and 45V. It was hoped that the decreased temp 
might limit the amount of tissue swelling. After three days some clearing was 
observed though markedly less than trials 2 and 3, with about the same amount of 
external damage Fig 15. 
 
 
N10 N9 Control 
 32 
 
Fig 15. N11 and N12 rat brains treated with electrophoretic tissue clearing, for 
CLARITY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N12 N11 Control 
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Discussion 
These acute studies were intended to show the effect of a central vs peripheral 
increase in sodium on cardiovascular and renal regulation of mean arterial pressure 
and natriuresis. Where the peripheral study was primarily concerned with increases 
in plasma sodium, the central study was aimed at eliminating alterations in plasma 
sodium so as to elucidate the relative contributions of the central nervous system to 
an acute sodium challenge. Both pre-treatment groups (SCR or Gαi2 ODN) in the 
central sodium study showed the increase in MAP that is characteristic of a central 
sodium challenge (22, 46), however the natriuretic response in the Gαi2 group was 
significantly attenuated. This is consistent with the observation that the reductions in 
sympathetic outflow in response to sodium loading is at least partially mediated by 
central nervous system Gαi2 protein gated signal transduction pathways (54). It was 
found when we challenged SCR and Gαi2 pre-treated animals peripherally with 3M 
NaCl that there was an increase in time to return to normotension in the Gαi2 animals 
vs their SCR counterparts. These observations serve to extend previous research from 
this laboratory that has shown an endogenous up-regulation of Gαi2 proteins within 
the PVN in response to chronic high salt intake and is required for maintaining 
normotension (26, 27). Interestingly while both the 1M NaCl ICV and 3M NaCl IV 
challenges showed some sort of attenuated response in the Gαi2 pre-treatment group, 
the response in the central challenge was related to natriuresis while the peripheral 
response was concerned with MAP. These results potentially illustrate two separate 
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mechanisms through which the body senses and then responds to increased sodium 
levels in either the CSF or the plasma. 
There is significant evidence in support of the subfornical organ (SFO) and the 
organum vasculosum of the lateral terminalis (OVLT) as the primary sensory organs 
responsible for changes in salt concentration and osmolarity within the central 
nervous system. Studies have shown a significant endogenous increase in the 
production of the Fos protein, a classical indicator of neural activity, in the CVOs in 
response to sodium loading or dehydration (39, 44). Additional studies have 
identified the presence of numerous different sodium channels including a 
disproportionate expression of ENaC channels within the SFO and OVLT (1, 35, 36). 
A Nax channel that has been shown to be sodium level sensitive has also been 
identified within the sensory CVOs (55). It has also been shown that an endogenous 
increase in Fos production within the CVOs that have shown an increased expression 
of ENaC, under an acute sodium infusion (36). It is interesting to note that both the 
SFO and OVLT lack a true blood brain barrier (17) and are therefore ideally situated 
to monitor sodium concentration in both the plasma and CSF. This cyto-architectural 
feature also presents an interesting question as to whether CSF, or plasma sodium, or 
a combination of the two is the primary force behind increased or decreased 
sympathetic output in response to higher or lower sodium values. No current studies 
have yet been able to definitively show whether it is increases in sodium or 
osmolarity in the CSF or the plasma that has a greater effect on the cells within this 
area.  
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Our new data as well as previous studies have shown that cardiovascular 
alterations in response to sodium are dose dependent in both peripheral and central 
sodium challenges (22, 54).  The ablation of the entire AV3V region in the dahl salt 
sensitive (DSS) rat has been shown to attenuate or abolish increases in mean arterial 
pressure in response to both chronic high salt intake and acute sodium challenges 
(46), although hypertension has been shown to still develop in spontaneously 
hypertensive rats even after the AV3V was lesioned (18). Studies in Sprague Dawley 
rats with chronic AV3V lesions on either a high or low salt diet have shown a near 
abolishment in any altered responses between dietary groups to central sodium 
loading that had previously been seen in animals with an intact AV3V on a high vs low 
salt diet (42). This evidence supports the argument that ablation of the AV3V may 
well attenuate the development of salt sensitive hypertension, although somewhat 
impractical as a treatment option for humans.   
 The results of our current immunohistochemical analysis demonstrated that 
there was no difference in the pre-treatment groups at control in terms of neuronal 
activity. After the administration of central sodium we found significantly increased 
levels of Fos expression in the PVN. These results confirm previous findings that 
higher sodium levels correspond to increased Fos production in this cardiovascular 
regulatory control center of the brain (36). Previous research has also shown 
increased Fos production in the SFO, OVLT, SON, and MnPO in response to increased 
sodium (41), as well as an increased sensitivity to salt in animals that are on a chronic 
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high salt diet (44). This increase in sensitivity is generally manifested as an increase 
in sympathetic nerve activity in response to a sodium load vs an animal that has not 
been on a chronic high salt diet, which is suggestive of a change in the way that salt is 
sensed over time (42). Additional results from this study have shown a significant 
difference in Fos production within the parvocellular neurons of the PVN between the 
two PT groups when challenged peripherally with 3M NaCl I.V. bolus, with a marked 
attenuation in Fos production in the PT group that lacked functional Gαi2 proteins. We 
have also noted that the Gαi2 pre-treated animals recovery time to normotension was 
significantly attenuated after peripheral sodium treatment. It is possible that this 
delayed return to normotension could result in consecutive salt loads, as could be 
expected by frequent high salt meals, leading to a slow progressive increase in MAP 
due to having not recovered to normal levels prior to the next salt load. These findings 
could illustrate a potential pathway for the pathogenesis of salt sensitive 
hypertension in human beings. Identification of such a pathway could be the first step 
in the targeted therapy that might halt the development of hypertension in salt 
sensitive individuals, although current methods to treat such an issue have yet to be 
reliably demonstrated. 
The understanding of the overall role of paraventricular nucleus 
magnocellular and parvocellular neurons remains somewhat ambiguous. Several 
studies have identified the role of the magnocellular neurons to be primarily 
neuroendocrine (3) with cells staining positively for oxytocin as well as vasopressin, 
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a hormone that has been historically associated with fluid balance. While we did 
observe a change in the Fos production in magnocellular neurons vs control after 
sodium treatment there was no significant difference between the two treatment 
groups, suggesting that magnocellular neurons likely play a negligible role in the G-
protein gated sympathoinhibitory pathway that is of primary interest to this study.  
Parvocellular neurons appear to be involved in the normal sympathoinhibitory 
pathways that are activated in the presence of high salt (45). Studies have traced 
projections from the PVN to the MnPO as well as the IML (49) both areas understood 
to play important roles in sympathetic control of vasculature. Our own findings have 
shown that a peripheral sodium challenge increased Fos production in the PVN 
parvocellular neurons, as well as showing that down regulation of Gαi2 significantly 
decreased this neural activation in response to salt. 
Our overall findings suggest an important role for central Gαi2 protein gated 
signal transduction in the normal presumably sympathoinhibitory response to 
increased sodium loading. These studies also help to illuminate that the body 
responds differently to increased sodium given peripherally (IV) as opposed to 
centrally (ICV). It was noteworthy that while in the peripheral study we saw an 
increase in the amount of time required for the Gαi2 ODN pre-treated animals to 
return to normotension, there was no such difference found in the animals challenged 
centrally. Additionally it was found that natriuresis was attenuated in Gαi2 ODN pre-
treated animals that were challenged centrally, however, no such differences were 
seen in the renal excretory parameters for the animals that were challenged 
 38 
peripherally.  This finding is consistent with the idea of two different salt driven 
presumably sympathoinhibitory responses which work cooperatively in normally 
functioning rats, with the implications that any sort of malfunction in either system 
could potentially result in the development of salt sensitive hypertension. Important 
to this study is the idea that while central Gαi2 protein pathways are vital to both 
central and peripheral responses to salt, it is possible that it is not the same Gαi2 
protein gated signal transduction pathways that are activated by each of the stimuli. 
This is illustrated by the differences seen in activation in PVN parvocellular neurons 
between the two treatment groups after a peripheral sodium load while such a 
difference is absent after a central sodium challenge. This could potentially be 
explained as evidence that the sympathoinhibitory Gαi2 protein gated signal 
transduction pathway has been evolutionarily conserved as organisms have 
increased in neural complexity. 
Clarity 
 The results of this study showed that it is possible to apply the CLARITY 
electrophoretic tissue clearing technique to larger organisms though whether or not 
it is possible to maintain the tissue integrity necessary for detailed studies of 
integrative systems involved in hypertension still remains unclear. Even given the 
limitations we encountered in our current studies the CLARITY technique or some 
form of it has already been utilized in number of other studies of complex 
neurological pathologies that include Alzheimer’s disease (2), Multiple Sclerosis (43), 
and some pioneering studies in addiction behaviors (21).   
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 Because of the relative novelty of the CLARITY method little has been 
published on the practice of clarifying large tissue and even less is posted about the 
use of CLARITY on rats, as a result we encountered several issues. One of the initial 
issues is that electrophoresis chambers designed for large volume tissue clearing are 
not yet commercially available and therefore have to be fabricated. There are a 
number of resources available with instructions for constructing small scale ETC 
chambers (48), however, most of these resources were intended for use with mice 
and not rats. We found that the important details related to chamber fabrication were 
that while the tissue needs to remain in the electric field for the best clearing result it 
can be highly detrimental if contact is made with either of the electrodes, so some 
steps should be taken to loosely secure the tissue in place. This serves a secondary 
function of protecting any sample from traumatic or abrasive effect of a constantly 
circulating solution. We found in early trials that leaving the tissue fully exposed to 
both the electrical field and the moving solution could slowly degrade the outer tissue 
that had already been cleared. The degradation of peripheral tissue presents some 
major issues to the study of hypertension since areas of the brain involved in body 
fluid homeostasis including the supra-optic nucleus are found peripherally. We used 
two cell IHC cell strainers caged together to hold the tissue in place as well as to 
provide a barrier from the electrodes, which helped to minimize tissue damage.  
 Another variable that we had some trouble with was the pH of the clearing 
solution. When the solution is initially prepared it is brought to a pH of 8.5, however, 
during the tissue clearing process acid can accumulate in the lipid mycelles lowering 
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the pH of the circulating solution. Once the pH of the clearing solution falls below 7 it 
becomes ineffective at clearing the specimen and any further acidity can risk 
damaging the remaining tissue so close monitoring of the clearing solution is 
necessary for the best results. In our experiments we used a water circulator that held 
around 2 liters of solution, during the first trial we ran each sample to completion 
before changing the solution. We altered this protocol to include changing the 
solution every 3 days to account for the higher accumulation of acids given the 
significant increase in tissue volume as a result of switching animal species. Regular 
changing of the clearing solution proved highly beneficial to the tissue clearing 
process.  
Degassing also presented a number of issues related to the new tissue size. 
Sample N1 was put under vacuum (-0.1atm) for a total of 10 min before addition of 
nitrogen gas. Due to the continued appearance of gas bubbles within the hydrogel 
after ten minutes sample N2 was kept under vacuum (-0.1atm) for a total of 20 
minutes before the addition of nitrogen, although bubbling still occurred the number 
of bubbles was markedly diminished after additional time under vacuum. Samples N3 
and N4 were both kept under vacuum for 30 min before introduction of nitrogen gas. 
Both samples N5 and N6 were placed under vacuum for 45 min before addition of 
nitrogen. Minimal bubbling was still evident at this point, however, continued time 
under vacuum was ruled out due to temperature constraints related to 
polymerization occurring if samples were allowed to warm to room temperature.  
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Overall we saw our best results with the tissue that was degassed under a 
vacuum for 45 min, followed by 7 days of ETC at 30V and 37°C, with a change of 
clearing solution after 3 and 6 days. Our results showed that the CLARITY method for 
optically clearing tissue as a means of tracking neuronal connections in intact 
specimens could plausibly be applied to the neural sympathoinhibitory pathway 
related to sodium dependent hypertension. Because of monetary and time restraints 
this study was not able to cover any of the staining or imaging protocols so further 
research will be necessary into the value of such a study but the early signs look 
promising.  
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APPENDIX 
1. 
 
 
Schematic drawings of 3 rostral-caudal levels of the hypothalamic paraventricular nucleus (PVN) 
that were sampled for analysis. Level 1 was the most rostral and included the dorsal parvocellular, 
medial parvocellular, and ventrally located posterior magnocellular subnuclei. Level 2 contained a 
prominent posterior magnocellular region and both dorsal and ventrolateral parvocellular 
divisions. Level 3 was the most caudal and consisted of the medial and lateral parvocellular 
divisions. Coordinates are in reference to bregma using standard sections from the atlas of 
Paxinos and Watson (40). dp, dorsal parvocellular; mp, medial parvocellular; vlp, ventrolateral 
parvocellular; lp, lateral parvocellular; 3V, 3rd ventricle. Figure and caption taken from Stocker et. 
al. 2004 (44) 
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